Abstract
Fast chiral liquid chromatographic methods are developed for the separation of bicalutamide and thalidomide enantiomers in bulk drug samples in an elution time of about 15 min. The chromatographic separation was carried out on various solvents using an amylose 3,5-dimethylphenylcarbamate immobilized onto silica gel (Chiralpak®-IA). The resolution (Rs) between the enantiomers is found to be greater than 1.5 in the developed method. Chiralpak®-IA column played a key role in achieving chromatographic resolution between the enantiomers and also in enhancing chromatographic efficiency. The columns compatability to non standard chromatographic solvents is checked and found suitable.
Keywords: Bicalutamide, Thalidomide, Chiralpak®-IA, Enantiomeric separation, Non-Steroidal Anti-Androgen, Sedative-Hypnotic, Multiple Myeloma, Pharmacokinetic, HPLC, Limit of Quantification, Precision, Robustness
Current Pharmaceutical Analysis
Title: Novel Chiral LC Methods for the Enantiomeric Separation of Bicalutamide and Thalidomide on Amylose Based Immobilized CSP
Volume: 7 Issue: 1
Author(s): I. V. Soma Raju, P. Raghuram and J. Sriramulu
Affiliation:
Keywords: Bicalutamide, Thalidomide, Chiralpak®-IA, Enantiomeric separation, Non-Steroidal Anti-Androgen, Sedative-Hypnotic, Multiple Myeloma, Pharmacokinetic, HPLC, Limit of Quantification, Precision, Robustness
Abstract: Fast chiral liquid chromatographic methods are developed for the separation of bicalutamide and thalidomide enantiomers in bulk drug samples in an elution time of about 15 min. The chromatographic separation was carried out on various solvents using an amylose 3,5-dimethylphenylcarbamate immobilized onto silica gel (Chiralpak®-IA). The resolution (Rs) between the enantiomers is found to be greater than 1.5 in the developed method. Chiralpak®-IA column played a key role in achieving chromatographic resolution between the enantiomers and also in enhancing chromatographic efficiency. The columns compatability to non standard chromatographic solvents is checked and found suitable.
Export Options
About this article
Cite this article as:
V. Soma Raju I., Raghuram P. and Sriramulu J., Novel Chiral LC Methods for the Enantiomeric Separation of Bicalutamide and Thalidomide on Amylose Based Immobilized CSP, Current Pharmaceutical Analysis 2011; 7 (1) . https://dx.doi.org/10.2174/157341211794708758
DOI https://dx.doi.org/10.2174/157341211794708758 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
Current Pharmaceutical Design Unlocking the Molecular Mechanisms of DNA Repair and Platinum Drug Resistance in Cancer Chemotherapy
Current Drug Therapy Latest Results for Anti-Angiogenic Drugs in Cancer Treatment
Current Pharmaceutical Design Importance of Wnt Signaling in the Tumor Stroma Microenvironment
Current Cancer Drug Targets RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review)
Anti-Cancer Agents in Medicinal Chemistry The Adipocyte as a Novel TSH Target
Mini-Reviews in Medicinal Chemistry Application of Pharmacogenomics to Dietary Cancer Chemoprevention
Current Pharmacogenomics Melanin-Concentrating Hormone as a Metabolic and Cognitive Regulatory Factor
Current Medicinal Chemistry - Central Nervous System Agents Recent Patents Related to Phosphorylation Signaling Pathway on Cancer
Recent Patents on DNA & Gene Sequences Editorial [Hot Topic: Targeting the IGF-I Receptor Signaling Pathway:Implications for Human Cancer Therapy (Executive Editors: A. Ciampolillo and F. Giorgino) ]
Current Pharmaceutical Design Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Current Pharmaceutical Design Targeted Therapy Towards Cancer-A Perspective
Anti-Cancer Agents in Medicinal Chemistry PPARγ in Angiogenesis and Vascular Development
Current Angiogenesis (Discontinued) Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy
Current Cancer Therapy Reviews Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Current Genomics Therapeutic Targeting of Apoptotic Pathways in Cancer
Current Drug Targets Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases
Current Cancer Drug Targets Recent Progress in Chemically Modified siRNAs
Mini-Reviews in Medicinal Chemistry Molecular Imaging: Translation from Rats to Dogs and Humans
Current Medical Imaging Gas1 is a Pleiotropic Regulator of Cellular Functions: from Embryonic Development to Molecular Actions in Cancer Gene Therapy
Mini-Reviews in Medicinal Chemistry